I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Favorskaya, Irina A.
15
results:
Search for persons
X
Format
Online (15)
Mediatypes
Articles (Online) (7)
OpenAccess-fulltext (8)
Sorted by: Relevance
Sorted by: Year
?
1
rAAV expressing recombinant antibody for emergency preventi..:
Esmagambetov, Ilias B.
;
Ryabova, Ekaterina I.
;
Derkaev, Artem A.
...
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
2
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 ..:
Favorskaya, Irina A.
;
Shcheblyakov, Dmitry V.
;
Esmagambetov, Ilias B.
...
Frontiers in Immunology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
3
Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemaggl..:
Voronina, Daria V.
;
Shcheblyakov, Dmitry V.
;
Favorskaya, Irina A.
...
Viruses. 14 (2022) 11 - p. 2485 , 2022
Link:
https://doi.org/10.3390/..
?
4
An open, non-randomised, phase 1/2 trial on the safety, tol..:
Tukhvatulin, Amir I.
;
Dolzhikova, Inna V.
;
Shcheblyakov, Dmitry V.
...
The Lancet Regional Health - Europe. 11 (2021) - p. 100241 , 2021
Link:
https://doi.org/10.1016/..
?
5
Safety and efficacy of an rAd26 and rAd5 vector-based heter..:
Logunov, Denis Y
;
Dolzhikova, Inna V
;
Shcheblyakov, Dmitry V
...
The Lancet. 397 (2021) 10275 - p. 671-681 , 2021
Link:
https://doi.org/10.1016/..
?
6
Expression and clinical significance of CRABP1 and CRABP2 i..:
Favorskaya, Irina
;
Kainov, Yaroslav
;
Chemeris, Galina
...
Tumor Biology. 35 (2014) 10 - p. 10295-10300 , 2014
Link:
https://doi.org/10.1007/..
?
7
CRABP1 provides high malignancy of transformed mesenchymal ..:
Kainov, Yaroslav
;
Favorskaya, Irina
;
Delektorskaya, Vera
...
Cell Cycle. 13 (2014) 10 - p. 1530-1539 , 2014
Link:
https://doi.org/10.4161/..
?
8
rAAV expressing recombinant antibody for emergency preventi..:
Esmagambetov, Ilias B
;
Ryabova, Ekaterina I
;
Derkaev, Artem A
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098153/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
9
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 ..:
Favorskaya, Irina A
;
Shcheblyakov, Dmitry V
;
Esmagambetov, Ilias B
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907979/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
10
CRABP1 provides high malignancy of transformed mesenchymal ..:
Kainov, Yaroslav
;
Favorskaya, Irina
;
Delektorskaya, Vera
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050158/. , 2014
Link:
http://www.ncbi.nlm.nih...
?
11
rAAV expressing recombinant antibody for emergency preventi..:
Ilias B. Esmagambetov
;
Ekaterina I. Ryabova
;
Artem A. Derkaev
...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1129245/full. , 2023
Link:
https://doi.org/10.3389/..
?
12
Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemaggl..:
Daria V. Voronina
;
Dmitry V. Shcheblyakov
;
Irina A. Favorskaya
...
Viral Immunology, Vaccines, and Antivirals. , 2022
Link:
https://doi.org/10.3390/..
?
13
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 ..:
Irina A. Favorskaya
;
Dmitry V. Shcheblyakov
;
Ilias B. Esmagambetov
...
https://www.frontiersin.org/articles/10.3389/fimmu.2022.822159/full. , 2022
Link:
https://doi.org/10.3389/..
?
14
Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemaggl..:
Daria V. Voronina
;
Dmitry V. Shcheblyakov
;
Irina A. Favorskaya
...
https://www.mdpi.com/1999-4915/14/11/2485. , 2022
Link:
https://doi.org/10.3390/..
?
15
An open, non-randomised, phase 1/2 trial on the safety, tol..:
Amir I. Tukhvatulin
;
Inna V. Dolzhikova
;
Dmitry V. Shcheblyakov
...
http://www.sciencedirect.com/science/article/pii/S2666776221002271. , 2021
Link:
https://doi.org/10.1016/..
1-15
